CL vs INTS
Colgate-Palmolive Company (CL) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
INTS does not have a complete income-statement cache yet.
CL currently screens at market cap $70.88B and trailing P/E 34.3. INTS currently screens at market cap $7.7M.
Not investment advice. Open the CL and INTS stock pages for the full models.
Not investment advice.